MEDARBOR LLC
BRISTOL, PA

MedArbor LLC (M18000001516) is a Florida-based company specializing in multifaceted healthcare services, dedicated to addressing the dynamic needs of modern medical practices nationwide. Incorporated on February 12, 2018, with its mailing address at 200 Rittenhouse Circle, Bristol, PA, MedArbor has established itself as an expert provider of designated healthcare solutions for both providers and patients across the country. The company is renowned nationally for implementing successful health services within medical practices. Under the leadership of Miro Kesic (Member), it boasts a solid reputation in the industry for exceptional customer service and product offerings, particularly noted through its pharmacy services which have been used by healthcare professionals nationwide for over five years. MedArbor's commitment to enhancing patient care and practice efficiency is reflected in positive endorsements from healthcare providers and colleagues who recommend their outstanding expertise and experience. The company was reinstated on April 28, 2023, and filed its last annual report on April 16, 2024, for the year 2024. For more information about MedArbor LLC and its offerings, please visit [medarbor.com](http://www.medarbor.com).

KEY FACTS ABOUT MEDARBOR LLC

Company name
MEDARBOR LLC
Status
Active
Filed Number
M18000001516
FEI Number
270730954
Date of Incorporation
February 12, 2018
Age - 8 years
Home State
PA
Company Type
Foreign Limited Liability

CONTACTS

Website
http://medarbor.com
Phones
(888) 590-0808
(866) 740-4689
(888) 740-4689

MEDARBOR LLC NEAR ME

Principal Address
200 Rittenhouse Circle, East,
Suite 5,
BRISTOL,
PA,
19007,
US

See Also

Officers and Directors

The MEDARBOR LLC managed by the one person from BRISTOL on following positions: Memb

Miro Kesic

Position
Memb Active
From
BRISTOL, PA, PA





Registered Agent is REGISTERED AGENT SOLUTIONS, INC.

Address
2894 REMINGTON GREEN LANE, TALLAHASSEE, FL, 32308

Events

April 28, 2023
REINSTATEMENT
September 23, 2022
REVOKED FOR ANNUAL REPORT

Annual Reports

2025
February 24, 2025
2024
April 16, 2024